Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study.
Frontiers in Neuroscience 2026 Jenna E Kachmarik, Jennifer M Loftis, Christopher S. Stauffer
Posttraumatic stress disorder (PTSD) is associated with elevated inflammation and risk for chronic illness, yet few studies have examined inflammatory biomarker outcomes of PTSD interventions. Rapid PTSD symptom reduction has been observed following 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy, which leverages MDMA as a prosocial adjunct to psychotherapy. No studies have evaluated...